Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-03-21
2006-03-21
Steadman, David J. (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S802000, C514S834000, C530S380000, C530S381000, C530S383000, C530S384000
Reexamination Certificate
active
07015193
ABSTRACT:
Disclosed are compositions for treating blood coagulation disorders and allows for manipulation of the blood coagulation cascade. More particularly the invention, relates to compositions for altering bleeding that include a mixture of at least one blood coagulation factor in a low dose and phospholipid vesicles. The invention has a variety of important uses including controlling bleeding in a mammal that has or is suspected of having a potentially life-threatening blood coagulation disorder.
REFERENCES:
patent: 6248353 (2001-06-01), Singh
Fatouros et al. Recombinant Factor VIII SQ—Stability of VIII:C in Homogenates from Porcine, Monkey, Human Subcutaneous Tissue (Jul. 2000) J. Pharm. Pharmacol. vol. 52, pp. 797-805.
Lawson et al. Cooperative Activation of Human Factor IX by the Human Extrinsic Pathway of Blood Coagulation (1991) J. Biol. Chem. vol. 266, No. 17, pp. 11317-1327.
Monroe et al. Mechanism of Action of High-Dose Factor VIIa, Points of Agreement and Disagreement (2003) Arterioscler. Thromb. Vasc. Biol. vol. 23, pp. 8-9.
Butenas et al. Influence of Factor VIIa and Phospholipids on Coagulation in “Acquired” Hemophilia (2003) vol. 23, pp. 123-129.
Lawson et al. The Activation of Factor IX by the Tissue Factor/Factor VIIa and Factor Xa/PCPS Enzyme Complexes in a Completely Human System. (1990) Circulation, vol. 82, No. 4, Suppl. III, pp. 304, abstract 1207.
S. Raut et al.,Brit. J. Haem., 107:323-329 (1999).
P. Lollar et al.,Blood, 63(6):1303-1308 (1984).
A. R. Giles et al.,Blood, 59(2):401-407 (1982).
J. M. Beals et al.,Biochem, J. 235:861-869 (1986).
D. L. Higgins et al.,The Journal of Biological Chemistry; 258(10):6503-6508 (1983).
Brummel Kathleen
Butenas Saulius
Mann Kenneth G.
Buchanan Robert L.
Conlin David G.
Edwards Angell Palmer & & Dodge LLP
Schnizer Holly
Steadman David J.
LandOfFree
Compositions and methods to control bleeding does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods to control bleeding, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods to control bleeding will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3587148